| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0M | — | +577.5% |
| Cost of Revenue | $12.0M | — | +527.9% |
| Gross Profit | -$9.0M | — | -513.0% |
| R&D Expense | $19.0M | — | +176.7% |
| SG&A Expense | $14.9M | — | +214.0% |
| Operating Income | -$51.8M | — | -245.1% |
| Pre-tax Income | -$49.7M | — | -275.7% |
| Income Tax | -$648K | — | — |
| Net Income | -$49.0M | — | -270.8% |
| EPS (Basic) | -$0.65 | — | -182.6% |
| EPS (Diluted) | -$0.65 | — | -182.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $47.1M | -55.7% | -76.2% |
| Accounts Receivable | $3.9M | +363.2% | +933.4% |
| Current Assets | $201.1M | -16.6% | +0.6% |
| Total Assets | $340.8M | -7.3% | +57.3% |
| Current Liabilities | $19.7M | +48.4% | +275.3% |
| Total Liabilities | $23.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$41.4M | — | -337.7% |
| Capital Expenditures | $1.4M | — | -58.3% |
| Investing Cash Flow | -$19.6M | — | -494.4% |
| Financing Cash Flow | $1.9M | — | -97.8% |
| Free Cash Flow | -$42.9M | — | -231.7% |
| +257.9% |
| Stockholders' Equity | $317.8M | -9.4% | +51.2% |